Sarco (Endo) Plasmic Reticulum Calcium Atpases (SERCA) Isoforms in the Normal and Diseased Cardiac, Vascular and Skeletal Muscle

Deregulated or enhanced calcium ion (Ca2+) influx across an unstable sarcolemma has been proposed to directly affect cardiac hypertrophic remodelling, vascular proliferative diseases and degenerative muscle disorders. Aberrant intracellular handling is partly due to a defect in Sarcoplasmic Reticulum (SR) function. Decreased Ca2+ uptake in cardiac, vascular and skeletal myocytes is associated with a decrease in the expression and activity of the fast sarco/endoplasmic reticulum Ca2+ ATPase (SERCA2a or SERCA1a isoforms). SERCA2a gene transfer was successfully used in heart failure; this approach holds further therapeutic promises in vascular proliferative diseases and dystrophin-deficient muscular diseases. The growing family of human SERCA isoforms comprises at least 14 mRNA and proteins with different functional characteristics and cell-specific expression. This review focuses on the biological role and therapeutic potential of different isoforms of SERCA in the physiology and pathology of cardiac, vascular and skeletal muscle cells.

[1]  D. Hamroun,et al.  The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome) , 2013, Neuromuscular Disorders.

[2]  R. Hajjar,et al.  Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases. , 2013, Current vascular pharmacology.

[3]  R. Samulski,et al.  Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy , 2013, Gene Therapy.

[4]  R. Hajjar,et al.  SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery , 2012, Gene Therapy.

[5]  R. Hajjar,et al.  A calcium-sensitive promoter construct for gene therapy , 2012, Gene Therapy.

[6]  N. Déliot,et al.  Dystrophin/α1-syntrophin scaffold regulated PLC/PKC-dependent store-operated calcium entry in myotubes. , 2012, Cell calcium.

[7]  R. Hajjar,et al.  Calcium Cycling in Synthetic and Contractile Phasic or Tonic Vascular Smooth Muscle Cells , 2012 .

[8]  R. Hajjar,et al.  Molecular targets in heart failure gene therapy: current controversies and translational perspectives , 2012, Annals of the New York Academy of Sciences.

[9]  N. Demaurex,et al.  Morphological and functional aspects of STIM1-dependent assembly and disassembly of store-operated calcium entry complexes. , 2012, Biochemical Society transactions.

[10]  R. Hajjar,et al.  SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice , 2011, Journal of Translational Medicine.

[11]  Barry Greenberg,et al.  Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.

[12]  I. Karakikes,et al.  SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells. , 2011, Journal of molecular and cellular cardiology.

[13]  Yoshiaki Kawase,et al.  Rescuing the failing heart by targeted gene transfer. , 2011, Journal of the American College of Cardiology.

[14]  R. Hajjar,et al.  Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. , 2011, The Journal of clinical investigation.

[15]  G. Salido,et al.  The TRPC ion channels: association with Orai1 and STIM1 proteins and participation in capacitative and non-capacitative calcium entry. , 2011, Advances in experimental medicine and biology.

[16]  S. Fisher.  Vascular smooth muscle phenotypic diversity and function. , 2010, Physiological genomics.

[17]  R. Levine,et al.  Gene Delivery of Sarcoplasmic Reticulum Calcium ATPase Inhibits Ventricular Remodeling in Ischemic Mitral Regurgitation , 2010, Circulation: Heart Failure.

[18]  R. Bobe,et al.  Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart. , 2010, Journal of molecular and cellular cardiology.

[19]  Iain S. Young,et al.  Immunohistochemical evidence for expression of fast-twitch type sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA1) in German shepherd dogs with dilated cardiomyopathy myocardium. , 2010, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

[20]  M. Lohse,et al.  Ca2+ cycling and new therapeutic approaches for heart failure. , 2010, Circulation.

[21]  D. Allen,et al.  Calcium and the damage pathways in muscular dystrophy. , 2010, Canadian journal of physiology and pharmacology.

[22]  R. Hajjar,et al.  Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure , 2010, Expert opinion on biological therapy.

[23]  C. Cognard,et al.  Regulation of TRPC1 and TRPC4 Cation Channels Requires an α1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes* , 2009, The Journal of Biological Chemistry.

[24]  F. del Monte,et al.  Compartmentalized expression of three novel sarco/endoplasmic reticulum Ca2+ATPase 3 isoforms including the switch to ER stress, SERCA3f, in non-failing and failing human heart. , 2009, Cell calcium.

[25]  J. Kaplan.  Gene table of monogenic neuromuscular disorders (nuclear genome only) Vol 19. No 1 January 2009. , 2009, Neuromuscular disorders : NMD.

[26]  M. Schuermans,et al.  Tight interplay between the Ca2+ affinity of the cardiac SERCA2 Ca2+ pump and the SERCA2 expression level. , 2007, Cell calcium.

[27]  Anuradha Kalyanasundaram,et al.  SERCA pump isoforms: Their role in calcium transport and disease , 2007, Muscle & nerve.

[28]  C. Cognard,et al.  Regulation of capacitative calcium entries by α1‐syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of α1‐syntrophin , 2007 .

[29]  C. Cognard,et al.  Regulation of capacitative calcium entries by alpha1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  中森 雅之,et al.  Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca[2+]-ATPase in myotonic dystrophy type 1 , 2007 .

[31]  JoAnn Buchanan,et al.  Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane , 2006, The Journal of cell biology.

[32]  P. Carmeliet,et al.  A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span. , 2006, Journal of molecular and cellular cardiology.

[33]  J. Soboloff,et al.  Orai1 and STIM Reconstitute Store-operated Calcium Channel Function* , 2006, Journal of Biological Chemistry.

[34]  A. Villemain,et al.  Sarco/endoplasmic reticulum Ca2+ATPase type 3 isoforms (SERCA3b and SERCA3f): distinct roles in cell adhesion and ER stress. , 2006, Biochemical and biophysical research communications.

[35]  M. Nadler,et al.  Amplification of CRAC current by STIM1 and CRACM1 (Orai1) , 2006, Nature Cell Biology.

[36]  R. Hajjar,et al.  Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c). , 2006, The Biochemical journal.

[37]  R. Hajjar,et al.  Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat , 2005, Circulation research.

[38]  R. Haddock,et al.  Rhythmicity in arterial smooth muscle , 2005, The Journal of physiology.

[39]  J. Lueck,et al.  Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. , 2005, Human molecular genetics.

[40]  Tobias Meyer,et al.  STIM Is a Ca2+ Sensor Essential for Ca2+-Store-Depletion-Triggered Ca2+ Influx , 2005, Current Biology.

[41]  S. Wagner,et al.  STIM1, an essential and conserved component of store-operated Ca2+ channel function , 2005, The Journal of cell biology.

[42]  C. Aalkjær,et al.  Vasomotion: cellular background for the oscillator and for the synchronization of smooth muscle cells , 2005, British journal of pharmacology.

[43]  M. Periasamy,et al.  Transgenic mouse models for cardiac dysfunction by a specific gene manipulation. , 2005, Methods in molecular medicine.

[44]  Godfrey L. Smith,et al.  Excessive Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase Expression Causes Increased Sarcoplasmic Reticulum Ca2+ Uptake but Decreases Myocyte Shortening , 2004, Circulation.

[45]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[46]  L. Dode,et al.  Identification, Expression, Function, and Localization of a Novel (Sixth) Isoform of the Human Sarco/Endoplasmic Reticulum Ca2+ATPase 3 Gene* , 2004, Journal of Biological Chemistry.

[47]  K. Sipido,et al.  Ca2+ transport ATPase isoforms SERCA2a and SERCA2b are targeted to the same sites in the murine heart. , 2003, Cell calcium.

[48]  A. Hovnanian,et al.  Dissection of the Functional Differences between Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) 1 and 2 Isoforms and Characterization of Darier Disease (SERCA2) Mutants by Steady-state and Transient Kinetic Analyses* , 2003, Journal of Biological Chemistry.

[49]  K. Sipido,et al.  Ca2+ Uptake by the Sarcoplasmic Reticulum in Ventricular Myocytes of the SERCA2b/b Mouse Is Impaired at Higher Ca2+ Loads Only , 2003, Circulation research.

[50]  P. Gélébart,et al.  Identification of a new SERCA2 splice variant regulated during monocytic differentiation. , 2003, Biochemical and biophysical research communications.

[51]  D. Maclennan,et al.  The Regulation of SERCA‐Type Pumps by Phospholamban and Sarcolipin , 2003, Annals of the New York Academy of Sciences.

[52]  B. Wolf,et al.  Insulin Receptor Substrate 1 Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 3 in Insulin-secreting β-Cells* , 2003, The Journal of Biological Chemistry.

[53]  B. Wolf,et al.  Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting beta-cells. , 2003, The Journal of biological chemistry.

[54]  R. Haddock,et al.  Differential activation of ion channels by inositol 1,4,5‐trisphosphate (IP3)‐ and ryanodine‐sensitive calcium stores in rat basilar artery vasomotion , 2002, The Journal of physiology.

[55]  K. Van Baelen,et al.  Dissection of the Functional Differences between Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) 1 and 3 Isoforms by Steady-state and Transient Kinetic Analyses* , 2002, The Journal of Biological Chemistry.

[56]  P. Gélébart,et al.  Three Novel Sarco/endoplasmic Reticulum Ca2+-ATPase (SERCA) 3 Isoforms , 2002, The Journal of Biological Chemistry.

[57]  Karin Sipido,et al.  Replacement of the Muscle-Specific Sarcoplasmic Reticulum Ca2+-ATPase Isoform SERCA2a by the Nonmuscle SERCA2b Homologue Causes Mild Concentric Hypertrophy and Impairs Contraction-Relaxation of the Heart , 2001, Circulation research.

[58]  P. Pinton,et al.  Serca1 Truncated Proteins Unable to Pump Calcium Reduce the Endoplasmic Reticulum Calcium Concentration and Induce Apoptosis , 2001, The Journal of cell biology.

[59]  T. Neild,et al.  Electrophysiological Basis of Arteriolar Vasomotion in vivo , 2000, Journal of Vascular Research.

[60]  Mark A Sussman,et al.  Overexpression of SERCA2b in the Heart Leads to an Increase in Sarcoplasmic Reticulum Calcium Transport Function and Increased Cardiac Contractility* , 2000, The Journal of Biological Chemistry.

[61]  H. Brinkmeier,et al.  Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. , 2000, Physiological reviews.

[62]  M. Nakasako,et al.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution , 2000, Nature.

[63]  Masayoshi Nakasako,et al.  Crystal structure of the calcium pump of sarcoplasmic reticulum at , 2000 .

[64]  U. Schmidt,et al.  Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. , 1999, Circulation.

[65]  R. Walsh,et al.  Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. , 1998, Circulation research.

[66]  Christopher C. Goodnow,et al.  Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.

[67]  T. Toyofuku,et al.  SR Ca(2+)-ATPase/phospholamban in cardiomyocyte function. , 1996, Journal of cardiac failure.

[68]  T. Toyofuku,et al.  SR Ca2+-ATPase/phospholamban incardiomyocyte function , 1996 .

[69]  J. Taylor,et al.  Sarcoplasmic reticulum Ca2+ pump expression in denervated skeletal muscle. , 1994, The American journal of physiology.

[70]  L. Dode,et al.  A sarco/endoplasmic reticulum Ca(2+)-ATPase 3-type Ca2+ pump is expressed in platelets, in lymphoid cells, and in mast cells. , 1994, The Journal of biological chemistry.